


FDA Approves First Interchangeable Biosimilar to Adalimumab, Plus a Combination Drug Approved
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira

Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis

Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

Upadacitnib for RA: Researchers Compared Upadacitinib with Placebo & Adalimumab in Patients with RA & an Inadequate Response to Methotrexate
Oxford University to Study Adalimumab as Potential COVID-19 Treatment
Biologic Spending & Price Trends
Humira, Rituxan Top List of U.S. Drugs with Biggest Price Increases

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis
- 1
- 2
- 3
- …
- 9
- Next Page »